Sundstrom S A, Komm B S, Xu Q, Boundy V, Lyttle C R
Department of Obstetrics and Gynecology, University of Pennsylvania, Philadelphia 19104.
Endocrinology. 1990 Mar;126(3):1449-56. doi: 10.1210/endo-126-3-1449.
We have previously demonstrated that complement component C3 is regulated by estradiol in the rat uterus. The antiestrogens tamoxifen, LY117018, and LY156758 exert both agonist and antagonist effects on the immature rat uterus. In this study, these three antiestrogens also stimulated an increase in the synthesis and secretion of C3. The combination of LY117018 and estradiol did not increase C3 to a greater extent than LY117018 alone, which suggests a similar mechanism of regulation. The regulation may be transcriptional since both estradiol and tamoxifen increase the concentration of C3 mRNA. Results of in situ hybridization revealed that the increase in C3 mRNA occurred in the luminal epithelial cells. Although the induction by estradiol and the antiestrogens was similar in most aspects, the time course for tamoxifen-stimulated synthesis differed from estradiol in that the time required to achieve maximal concentrations of C3 was delayed by 12 h with tamoxifen. This pattern did not appear to be related to the time it took to convert tamoxifen to 4-hydroxytamoxifen since the C3 response for these antiestrogens were identical. The antiestrogen-stimulated increase in C3 synthesis and mRNA concentration was prevented by the co-administration of progesterone lending support to the hypothesis that the antiestrogens regulate C3 synthesis via a mechanism similar to estrogen.
我们先前已证明,补体成分C3在大鼠子宫中受雌二醇调节。抗雌激素药物他莫昔芬、LY117018和LY156758对未成熟大鼠子宫发挥激动剂和拮抗剂双重作用。在本研究中,这三种抗雌激素药物也刺激了C3合成与分泌的增加。LY117018与雌二醇联合使用时,C3增加的程度并不比单独使用LY117018时更大,这表明存在相似的调节机制。这种调节可能是转录性的,因为雌二醇和他莫昔芬均可增加C3 mRNA的浓度。原位杂交结果显示,C3 mRNA的增加发生在腔上皮细胞中。尽管在大多数方面,雌二醇和抗雌激素药物的诱导作用相似,但他莫昔芬刺激合成的时间进程与雌二醇不同,即他莫昔芬达到C3最大浓度所需的时间延迟了12小时。这种模式似乎与他莫昔芬转化为4-羟基他莫昔芬所需的时间无关,因为这些抗雌激素药物对C3的反应是相同的。同时给予孕酮可阻止抗雌激素药物刺激的C3合成增加和mRNA浓度升高,这支持了抗雌激素药物通过类似于雌激素的机制调节C3合成的假说。